Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Sanders

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Ebiomedicine|October 20, 2024
Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotypeManukumar Honnayakanahalli Marichannegowda, Saini Setua, Meera Bose, et al.
AIDS (London, England)|November 26, 2019
Activated PD-1+ CD4+ T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ARTMichael A Eller, Ting Hong, Matthew Creegan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2019
New Subtype B Containing HIV-1 Circulating Recombinant of sub-Saharan Africa Origin in Nigerian Men Who Have Sex With MenErik Billings, Gustavo H Kijak, Eric Sanders-Buell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 13, 2018
Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular ClonesAgnes-Laurence Chenine, Melanie Merbah, Lindsay Wieczorek, et al.
Plos One|December 7, 2013
Impact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backboneAgnès-Laurence Chenine, Lindsay Wieczorek, Eric Sanders-Buell, et al.
Virology Journal|July 2, 2024
Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AGLindsay Wieczorek, David Chang, Eric Sanders-Buell, et al.
Biomolecular Detection and Quantification|March 30, 2019
Next-generation sequencing of HIV-1 single genome ampliconsGustavo H Kijak, Eric Sanders-Buell, Phuc Pham, et al.
Plos One|August 20, 2015
The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006Erik Billings, Eric Sanders-Buell, Meera Bose, et al.
Journal of Virology|June 23, 2021
Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization BreadthYifan Li, Hongjun Bai, Eric Sanders-Buell, et al.
Ebiomedicine|November 8, 2023
Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting: the RV217 acute infection cohort studyManukumar Honnayakanahalli Marichannegowda, Michelle Zemil, Lindsay Wieczorek, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Ebiomedicine|October 20, 2024
Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotypeManukumar Honnayakanahalli Marichannegowda, Saini Setua, Meera Bose, et al.
AIDS (London, England)|November 26, 2019
Activated PD-1+ CD4+ T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ARTMichael A Eller, Ting Hong, Matthew Creegan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2019
New Subtype B Containing HIV-1 Circulating Recombinant of sub-Saharan Africa Origin in Nigerian Men Who Have Sex With MenErik Billings, Gustavo H Kijak, Eric Sanders-Buell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 13, 2018
Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular ClonesAgnes-Laurence Chenine, Melanie Merbah, Lindsay Wieczorek, et al.
Plos One|December 7, 2013
Impact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backboneAgnès-Laurence Chenine, Lindsay Wieczorek, Eric Sanders-Buell, et al.
Virology Journal|July 2, 2024
Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AGLindsay Wieczorek, David Chang, Eric Sanders-Buell, et al.
Biomolecular Detection and Quantification|March 30, 2019
Next-generation sequencing of HIV-1 single genome ampliconsGustavo H Kijak, Eric Sanders-Buell, Phuc Pham, et al.
Plos One|August 20, 2015
The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006Erik Billings, Eric Sanders-Buell, Meera Bose, et al.
Journal of Virology|June 23, 2021
Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization BreadthYifan Li, Hongjun Bai, Eric Sanders-Buell, et al.
Ebiomedicine|November 8, 2023
Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting: the RV217 acute infection cohort studyManukumar Honnayakanahalli Marichannegowda, Michelle Zemil, Lindsay Wieczorek, et al.
Pageof 9